期刊文献+

Mohnarin 2011年度报告:中南地区细菌耐药监测 被引量:19

Mohnarin report of 2011:monitoring of bacterial resistance in central-southern China
原文传递
导出
摘要 目的分析中南地区2011年临床分离菌的分布特征和对常用抗菌药物的耐药性,为临床用药提供参考依据。方法采用纸片扩散法或自动化仪器法对2011年中南地区6所医院临床分离菌株进行药敏试验,按CLSI2011年标准判定药敏结果,采用WHONET5.6软件进行数据分析。结果中南地区2011年共分离细菌23 985株,其中革兰阴性菌占69.3%,革兰阳性菌占30.7%,前5位病原菌依次为大肠埃希菌、铜绿假单胞菌、金黄色葡萄球菌、鲍氏不动杆菌、肺炎克雷伯菌,耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(MRSCN)检出率分别为54.3%和75.6%;肠球菌属对万古霉素、替考拉宁的耐药率均<2.0%,大肠埃希菌、克雷伯菌属和奇异变形菌中产ESBLs株分离率分别为74.8%、54.6%和14.5%,肠杆菌科细菌对碳青霉烯类抗菌药物最为敏感,敏感率为90.3%~100%,铜绿假单胞菌对美罗培南、亚胺培南的的耐药率<30.0%,而鲍氏不动杆菌对碳青霉烯类的耐药率接近50.0%,嗜麦芽寡养单胞菌对头孢他啶、替卡西林/克拉维酸的敏感率最低,<60.0%,对米诺环素、左氧氟沙星的敏感性最高,>80.0%,洋葱伯克菌对美罗培南和米诺环素的敏感率较高,>70.0%,对替卡西林/克拉维酸的敏感率最低为17.1%,流感嗜血菌β-内酰胺酶阳性率为44.8%,除对氨苄西林和磺胺甲噁唑/甲氧苄啶敏感率稍低外,对其他药物的敏感率大部分>70.0%。结论临床常见病原菌仍以革兰阴性杆菌为主,细菌耐药性呈上升趋势,特别是肠杆菌科细菌产ESBLs菌株增高明显,应重视耐万古霉素肠球菌、碳青霉烯类耐药肠杆菌及多药耐药革兰阴性杆菌的流行。 OBJECTIVE To investigate the antibiotics resistance of clinical isolates from central-southern China in 2011 so as to provide evidence for the clinical medication.METHODS The antimicrobial susceptibility testing of the clinical isolates from 6 hospitals in the central-southern China was tested by Kirby-Bauer method or automated system,the results were determined according to CLSI,2011,and the statistical analysis was performed by WHONET5.6.RESULTS A total of 23 985 strains were isolated from 6 hospitals in central-southern China in 2011,with 69.3% of the gram-negative bacilli and 30.7% of the gram-positive cocci.The top five species of pathogens were Escherichia coli,Pseudomonas aeruginosa,Staphylococcus aureus,Acinetobacter baumannii and Klebsiella pneumonia.The detection rates of the MRSA and MRSCN were 54.3% and 75.6%,respectively.Less than 2.0% of the Enterococcus spp were resistant to vancomycin or teicoplanin.The isolation rates of ESBLs-producing E.coli,Klebsiella spp and P.mirabilis were 74.8%,54.6%,and 14.5%,respectively.The drug susceptibility rates of Enterobacteriaceae to carbapenems ranged between 90.3% and 100%.The drug resistance rates of A.baumannii to imipenem and meropenem were about 50.0%,and less than 30.0% of P.aeruginosa.The S.maltaphilia isolates were most susceptible to levofloxacin and minocycline,with the drug susceptibility rates higher than 80.0%,and less than 60.0% to ceftazidime and ticarcillin-clavulanic acid.The drug susceptibility rates of Burkholderia to meropenem and minocycline were higher than 70.0% and was the lowest to ticarcillinclavulanic acid(17.1%).The isolation rates of β-lactamase-producing H.influenzae was 44.8%,the drug susceptibility rates to all the antibiotics were higher than 70.0% except ampcillin and sulfamethoxazole / trimethoprim.CONCLUSION The gram-negative bacilli remain prevalent in the clinical isolates,and bacterial resistance rate is on the rise.The prevalence of ESBLs-producing Enterobacteriaceae isolates increase significantly.Great attention should be paid to the prevalence of vancomycin-resistant Enterococci,carbapenems-resistant Enterobacteriaceae and multi-drug resistant gram-negative bacilli.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第22期4977-4982,共6页 Chinese Journal of Nosocomiology
基金 卫生行业科研专项项目(201002021)
关键词 卫生部全国细菌耐药监测网 中南地区 细菌 耐药性 监测 Mohnarin Central-southern China Bacteria Drug resistance Monitoring
  • 相关文献

参考文献10

  • 1Clinical and Laboratory Standards Institute. Performance standards for antimierobial susceptibility testing, twenty-first informational supplement[S]. M100-$21. CLSI, 2011.
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, twentieth informational supplement[S], M100-S20. CLSI, 2010.
  • 3孔海深,杨青,陈晓,张伟丽,魏泽庆,沈萍,肖永红,李兰娟.Mohnarin 2010年度报告:中南地区细菌耐药监测[J].中华医院感染学杂志,2011,21(23):4921-4926. 被引量:13
  • 4肖永红,沈萍,魏泽庆,陈云波,孔海深,杨青,张伟丽,陈晓,李兰娟.Mohnarin 2010年度全国细菌耐药监测[J].中华医院感染学杂志,2011,21(23):4896-4902. 被引量:132
  • 5Musta A C, Riederer K, Shemes S, et al. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years[J]. Clin Microbiol, 2009, 47(6):1640-1644.
  • 6窦红涛,谢秀丽,张小江,等.Mohnarin2008年度报告:肠杆菌科细菌耐药监测[J].中国抗菌药物杂志,2010,35(7):556-564.
  • 7Nordmann P, Cuzon G, Naas T, The real threat of Klehsiella pneumoniae earbapenemase-producing bacteria[J]. Lancet In ect Dis, 2009, 9(4): 228-236.
  • 8Wu Q, Liu Q, Han L, et al. Plasmid-mediated carbapenem- hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring hlgh-level aminoglyeoside resistance in carbapenem- resistant Enterobaeter cloacae in China[J]. Diagn Mierobiol Infect Dis, 2010, 66(3): 326-328.
  • 9Cai J C, Zhou H W, Zhang R, et al. Emergence of Serratia marcescens , Klebsiella pneumoniae , and Escherichia coli iso- lates possessing the plasmid-mediated carbapenem hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hos- pital[J]. Antimicrob Agents Chemother, 2008, 52: 2014- 2018.
  • 10孔海深,杨青,陈晓,张伟丽,肖永红,李兰娟.Mohnarin 2010年度报告:华东地区细菌耐药监测[J].中华医院感染学杂志,2011,21(23):4915-4920. 被引量:25

二级参考文献21

  • 1XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, twentieth informational supplement[S]. M100-S20. CLSI,2010.
  • 3Nordmann P,Culon G,Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria[J]. Lancet In- fect Dis,2009,9(4):228-236.
  • 4Wu Q, Liu Q, Han L,et al. Plasmid-mediated carbapenem-hy- drolyzing enzyme KPC-2-and ArmA 16S rRNA methylase con- ferring high-level aminoglycoside, resistance in carbapenem-re-sistant Enterobacter cloacae in China[J]. Diagn Microbiol In- fect Dis,2010,66(3) :326-328.
  • 5Cai JC,Zhou HW,Zhang R,et al. Emergence of Serratia marees cens, Klebsiella pneumoniae , and Escheriehia coli isolates posses sing the plasmid-mediated earbapenem hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital[J]. Antimicrob Agents Chemother, 2008,52 (6) :2014-2018.
  • 6Schwaber MJ,Navon-Venezia S,Carmeli Y. High level of an- timicrobial co-resistance among extended-spectrum β- lacta- mase-producing Enterobaeteriaceae [ J]. Antimicrob Agents Chem other,2005,49(5):2137-2139.
  • 7Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, twentieth informational supplement[S]. M100-S20. CLSI,2010.
  • 8Musta AC, Riederer K, Shemes S, et al. Vancomycin MIC plus heteroresistance and outcome of methieillin resistant Staphy lococcus aureus bacteremia: trends over 11 years[J]. Clin Mi- crobiol, 2009,47(6) : 1640-1644.
  • 9Schwaber MJ,Navon-Venezia S,Carmeli Y. High level of an- timicrobial co resistance among extended-spectrum t?-lacta- mase producing Enterobacteriaceae [J]. Antimicrob Agents Chemother,2005,49(5):2137-2139.
  • 10Nordmann P,Cuzon G, Naas T. The real threat of Klebsiella pneumoniae earbapenemase-producing bacteria[J]. Lancet In fect Dis, 2009,9(4) :228-236.

共引文献159

同被引文献176

引证文献19

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部